米索前列醇联合B超在扩宫失败患者中的应用观察

Clinical observation of Misoprostol combined with B-ultrasonography applied in the patients failed to have cervix dilated

目的探讨米索前列醇联合B超在扩宫失败患者中的应用价值。方法 84例院外取宫内节育器(intrauterine contraceptivedevice,IUD)扩宫失败转入成都市计划生育指导所需再次手术的患者,分为两组,A组42例采取经宫腔镜手术;B组42例,术前给予米索前列醇术中联合B超引导扩宫。比较两组扩宫时间、扩宫成功率。结果 A组扩宫时间(58.92±26.97)s,扩宫成功率76.19%;B组扩宫时间(30.5±8.02)s,扩宫成功率97.62%。两组扩宫时间、扩宫成功率比较差异有统计学意义(P<0.05)。结论米索前列醇术前充分软化宫颈,术中联合B超引导,其提高扩宫成功率优于宫腔镜手术。

Objective To investigate the clinical value of Misoprostol combined with B-ultrasonography applied in the patients who had failed to have cervix dilated. Methods 84 patients who failed to have cervix dilated in other clinics, were prepared to be re -operate in our hospital. They were equally divided into 2 groups. In group A ,42 cases had hysteroseopie operation, whiled in group B, metreurysis were carried out ＇after the applieation of Misoprostol combined with B - uhrasonography. The dilation time and success rates of two groups were compared. Results The duration time of metreurysis in groups A was 58. 92± 26. 97 second, and the success rate was 76. 2%. While in group B,the duration time was 30. 5 ± 8.02 second, and the success rate was 97. 6%. Two groups＇ differences were significant （p 〈0. 05）. Conclusion Misoprostol combined with B - uhrasonography is superior to traditional hysteroscopy.